Company Overview of Enchira Biotechnology Corporation
In January 2003, Enchira Biotechnology Corporation’s stockholders approved the plan of complete liquidation and dissolution of the company. Previously, it was a drug discovery and development company that was engaged in development of therapeutic proteins to inhibit receptor tyrosine kinases and their role in certain types of cancer.
4200 Research Forest Drive
The Woodlands, TX 77381
Key Executives for Enchira Biotechnology Corporation
Enchira Biotechnology Corporation does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
|3D Biomatrix Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Enchira Biotechnology Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.